Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Breuning

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Journal of the American Society of Nephrology : JASN|November 30, 1999
Aberrant splicing in the PKD2 gene as a cause of polycystic kidney diseaseD M Reynolds, T Hayashi, Y Cai, et al.
Cytogenetic and Genome Research|September 29, 2007
Variation of CNV distribution in five different ethnic populationsS J White, L E L M Vissers, A Geurts van Kessel, et al.
Leukemia|February 3, 1998
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.
American Journal of Human Genetics|October 27, 1997
A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)B Veldhuisen, J J Saris, S de Haij, et al.
Clinical Genetics|May 22, 2010
X-chromosome duplications in males with mental retardation: pathogenic or benign variants?A C J Gijsbers, N S den Hollander, A T J M Helderman-van de Enden, et al.
Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.
Kidney International|April 12, 2000
Location of mutations within the PKD2 gene influences clinical outcomeN Hateboer, B Veldhuisen, D Peters, et al.
Leukemia|September 1, 1996
Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemiaB A van der Reijden, D Martinet, J G Dauwerse, et al.
Familial Cancer|October 24, 2003
Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive casesY M C Hendriks, J T C M Verhallen, J J van der Smagt, et al.
Journal of Medical Genetics|June 14, 2008
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variantF D Hannes, A J Sharp, H C Mefford, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Journal of the American Society of Nephrology : JASN|November 30, 1999
Aberrant splicing in the PKD2 gene as a cause of polycystic kidney diseaseD M Reynolds, T Hayashi, Y Cai, et al.
Cytogenetic and Genome Research|September 29, 2007
Variation of CNV distribution in five different ethnic populationsS J White, L E L M Vissers, A Geurts van Kessel, et al.
Leukemia|February 3, 1998
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)R H Giles, J G Dauwerse, C Higgins, et al.
American Journal of Human Genetics|October 27, 1997
A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)B Veldhuisen, J J Saris, S de Haij, et al.
Clinical Genetics|May 22, 2010
X-chromosome duplications in males with mental retardation: pathogenic or benign variants?A C J Gijsbers, N S den Hollander, A T J M Helderman-van de Enden, et al.
Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.
Kidney International|April 12, 2000
Location of mutations within the PKD2 gene influences clinical outcomeN Hateboer, B Veldhuisen, D Peters, et al.
Leukemia|September 1, 1996
Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemiaB A van der Reijden, D Martinet, J G Dauwerse, et al.
Familial Cancer|October 24, 2003
Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive casesY M C Hendriks, J T C M Verhallen, J J van der Smagt, et al.
Journal of Medical Genetics|June 14, 2008
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variantF D Hannes, A J Sharp, H C Mefford, et al.
Pageof 17